(Q34022223)

30 July 2017

1 reference

title

Tumor-stromal interactions in bone metastasis (English)

1 reference

30 July 2017

Kalyan C Nannuru

1

1 reference

30 July 2017

Rakesh K Singh

series ordinal

2

1 reference

30 July 2017

publication date

1 June 2010

1 reference

Current osteoporosis reports

30 July 2017

published in

1 reference

30 July 2017

volume

8

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

105-113

1 reference

https://scigraph.springernature.com/pub.10.1007/s11914-010-0011-6

30 July 2017

exact match

0 references

cites work

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-010-0011-6

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11914-010-0011-6

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

21 January 2018

1 reference

12 December 2020

Breast cancer cells interact with osteoblasts to support osteoclast formation

1 reference

12 December 2020

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

12 December 2020

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway

1 reference

12 December 2020

The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells

1 reference

12 December 2020

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment

1 reference

12 December 2020

Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts

1 reference

12 December 2020

Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts

1 reference

12 December 2020

Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice

1 reference

12 December 2020

Mechanisms of bone metastases of breast cancer

1 reference

12 December 2020

Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand

1 reference

12 December 2020

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis

1 reference

12 December 2020

Chemokines in tumor angiogenesis and metastasis

1 reference

12 December 2020

IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways

1 reference

12 December 2020

Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis

1 reference

12 December 2020

RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4.

1 reference

12 December 2020

MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration.

1 reference

12 December 2020

The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae

1 reference

12 December 2020

Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis

1 reference

12 December 2020

Transforming growth factor-beta signaling at the tumor-bone interface promotes mammary tumor growth and osteoclast activation.

1 reference

12 December 2020

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

1 reference

12 December 2020

Catabolism and turnover of collagens: collagenases

1 reference

12 December 2020

The distribution of secondary growths in cancer of the breast. 1889

1 reference

12 December 2020

A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma

1 reference

12 December 2020

MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

1 reference

12 December 2020

Inhibition of osteoclast differentiation and bone resorption by cathepsin K antisense oligonucleotides

1 reference

12 December 2020

Clinical patterns of metastasis

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model

1 reference

12 December 2020

Risks and benefits of bisphosphonates

1 reference

12 December 2020

Mechanisms of osteolytic bone metastases in breast carcinoma

1 reference

12 December 2020

Growth factor regulation of insulin-like growth factor binding protein-6 expression in osteoblasts

1 reference

12 December 2020

Chemokines and the molecular basis of cancer metastasis

1 reference

12 December 2020

Transforming Growth Factor-Beta in Osteolytic Breast Cancer Bone Metastases

1 reference

12 December 2020

Cathepsin G-mediated activation of pro-matrix metalloproteinase 9 at the tumor-bone interface promotes transforming growth factor-beta signaling and bone destruction

1 reference

12 December 2020

Proteases as modulators of tumor-stromal interaction: primary tumors to bone metastases

1 reference

12 December 2020

Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption

1 reference

12 December 2020

Molecular mechanisms of breast cancer metastases to bone

1 reference

12 December 2020

Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1.

1 reference

12 December 2020

The bone microenvironment in metastasis; what is special about bone?

1 reference

12 December 2020

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells

1 reference

12 December 2020

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

12 December 2020

Cancer micrometastases

1 reference

12 December 2020

The causes and treatment of bone loss associated with carcinoma of the breast

1 reference

12 December 2020

Adenovirus-mediated transfer of the HST-1 (FGF4) gene induces increased levels of platelet count in vivo

1 reference

12 December 2020

CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.

1 reference

12 December 2020

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

12 December 2020

Metastasis results from preexisting variant cells within a malignant tumor

1 reference

12 December 2020

Cathepsin G recruits osteoclast precursors via proteolytic activation of protease-activated receptor-1.

1 reference

12 December 2020

Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.

1 reference

12 December 2020

10.1007/S11914-010-0011-6

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1034353053

0 references

1 reference